Emergency Surgical Management of Newly Diagnosed Polycythemia Vera

Pre‑operative Management

• Proceed with emergency surgery without delay when clinically indicated, and plan close postoperative surveillance for thrombosis and bleeding; the risk of postponing life‑saving surgery outweighs hematologic abnormalities. – NCCN guidelines【1】【2】
• Coordinate a multidisciplinary team (surgery, anesthesia, hematology) before the operation. – NCCN guidelines【1】【2】
• Review the patient’s personal history of bleeding and thrombosis, recognizing that newly diagnosed patients may have limited prior events. – NCCN guidelines【1】
• Do not postpone emergency surgery to achieve optimal hematocrit; hematocrit control (< 45 %) is only feasible for elective cases. – NCCN guidelines【1】【3】
• For elective procedures, aim to keep hematocrit < 45 % for at least three months pre‑operatively; this target cannot be met in emergencies. – NCCN guidelines【3】
• Start peri‑operative hydroxyurea in newly diagnosed patients; cytoreductive therapy can be continued throughout the peri‑operative period unless the surgical team objects. – NCCN guidelines【3】
• Withhold aspirin in the presence of active bleeding or when the surgery carries high bleeding risk. – NCCN guidelines【1】【2】
• If the patient was on aspirin, discontinue it one week before elective surgery; in emergencies, proceed without aspirin. – NCCN guidelines【3】
• Resume aspirin 24 hours after surgery once adequate hemostasis is confirmed and bleeding risk is acceptable. – NCCN guidelines【3】

Intra‑operative Considerations

• Obtain coagulation studies (including assays for acquired von Willebrand disease) when platelet counts are elevated or splenomegaly is present, to detect coagulopathies that may affect surgical risk. – NCCN guidelines【1】【2】【7】
• Prioritize these coagulation assessments for high‑risk surgical procedures. – NCCN guidelines【1】【7】

Post‑operative Management

• Administer prophylactic low‑molecular‑weight heparin (LMWH) once surgical hemostasis is secured, typically 12–24 hours after the operation. – NCCN guidelines【1】【2】【4】
• For high‑risk surgeries (orthopedic, cardiovascular, oncologic, or those requiring prolonged immobilization), consider extended LMWH prophylaxis. – NCCN guidelines【1】【2】
• Delay LMWH re‑initiation 48–72 hours after surgeries with high bleeding risk. – American College of Chest Physicians (ACCP) guidelines【5】【6】
• Maintain vigilant monitoring for both thrombotic (deep‑vein thrombosis, pulmonary embolism, arterial occlusion) and hemorrhagic complications after surgery. – NCCN guidelines【1】【2】【4】
• Only life‑saving procedures should be performed shortly after recent coronary stent placement; other emergency surgeries may proceed as needed. – Urology guideline (The Journal of Urology)【8】
• Recognize that the inherent thrombotic and bleeding risks of polycythemia vera do not outweigh the necessity for emergency intervention. – NCCN guidelines【1】【2】

Critical Pitfalls to Avoid

• Do not delay emergency, life‑saving surgery to achieve hematologic targets; postponement increases overall morbidity. – NCCN guidelines【1】【2】
• In patients with splenomegaly or portal hypertension who develop gastrointestinal bleeding, involve gastroenterology/hepatology for endoscopic evaluation because gastric varices may be present. – NCCN guidelines【1】【7】

Long‑term Post‑operative Management

• Continue or initiate cytoreductive therapy post‑operatively to keep hematocrit < 45 % and normalize blood counts. – NCCN guidelines【1】【2】【7】
• Determine the need for long‑term anticoagulation based on any thrombotic events; duration should be longer for abdominal vein thrombosis than for peripheral deep‑vein thrombosis. – NCCN guidelines【1】【2】【7】
• Reserve plateletpheresis for acute, life‑threatening postoperative thrombosis. – NCCN guidelines【1】【7】